-

Nomi Health Announces Hours and Locations for COVID-19 Community Testing Sites in Alabama as Statewide COVID Cases Increase

In conjunction with local counties, three community testing sites ensure Alabama residents continue to have access to critical COVID-19 testing

ANNISTON, Ala.--(BUSINESS WIRE)--Nomi Health, the direct healthcare company coordinating COVID-19 testing and vaccination efforts across the country, today announced hours and locations for three community testing sites in Decatur, Athens, and Anniston to accommodate the rise in demand for COVID-19 testing as case counts rise across Alabama.

Local residents will be able to access efficient and quality testing without driving to Birmingham. Individuals in need of a test are asked to bring an insurance card if they have one. If they do not have insurance, they will not be turned away. Appointments are not required but you may pre-register by visiting https://nomihealth.com/alabama/ and select your location - Decatur, Athens, or Anniston.

Testing Sites:

Veterans Museum
100 Pryor St W, Athens, AL 35611
Hours of operation: 10am-6pm
Days: Monday-Saturday

Decatur - Fire Training Facility
4119 Old Highway 31, Decatur, AL 35603
Hours of operation: 9am-5pm
Days: Monday-Friday

Anniston - Leighton & 10th
230 E 10th St STE 206, Anniston, AL 36207
Hours of operation: 10am-6pm
Days: Sunday-Saturday

The sites offer PCR tests within a 24–48-hour turnaround time. The samples are processed in a CLIA-certified laboratory using FDA EUA-authorized test kits. Results will be available via email and text to the destination that was placed within the registration form.

For more information, please visit: https://nomihealth.com/alabama/.

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations, and constituents. We’re a team of over 2,000--each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real time. From the front lines of COVID testing and vaccination serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

Contacts

Media Contact
Francis Perdue
mPR, Inc. for Nomi Health
francis@mpublicrelations.com
205-635-9824 direct

Nomi Health


Release Versions

Contacts

Media Contact
Francis Perdue
mPR, Inc. for Nomi Health
francis@mpublicrelations.com
205-635-9824 direct

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom